[The role of delta agent in particularly severe acute hepatitis B and non-A, non-B hepatitis in HBsAg carriers].
Role of delta agent in course of acute hepatitis B of particular severity and of hepatitis nAnB in carriers of HBsAg. Eighty-four cases of acute viral hepatitis have been studied with regard to the positiveness for delta antigen and anti-delta antibody in the Laboratory of clinical-chemical and microbiological analyses of the Hospital "L. Sacco" of Milan. The cases have been grouped in two classes: acute B hepatitis with prothrombin time of less than 40% acute viral hepatitis nAnB in chronic carriers of HBsAg. The prevalence of delta hepatitis was of 47.1% in the first class, while it was of 22% in the second class.
D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D002353:Carrier State; D006509:Hepatitis B / Q000276:immunology / Q000382:microbiology*; D006514:Hepatitis B Surface Antigens; D006526:Hepatitis C / Q000276:immunology / Q000382:microbiology*; D003698:Hepatitis Delta Virus / Q000032:analysis* / Q000276:immunology; D006525:Hepatitis, Viral, Human / Q000382:microbiology*; D006801:Humans; D011517:Prothrombin Time
D000914:Antibodies, Viral; D000956:Antigens, Viral; D006514:Hepatitis B Surface Antigens
Il ruolo dell'agente delta in corso di epatite B acuta di particolare gravità e di epatite nAnB in portatori di HBsAg.